MA53914A - Polymorphes cristallins d'inhibiteurs de la tyrosine kinase de bruton - Google Patents
Polymorphes cristallins d'inhibiteurs de la tyrosine kinase de brutonInfo
- Publication number
- MA53914A MA53914A MA053914A MA53914A MA53914A MA 53914 A MA53914 A MA 53914A MA 053914 A MA053914 A MA 053914A MA 53914 A MA53914 A MA 53914A MA 53914 A MA53914 A MA 53914A
- Authority
- MA
- Morocco
- Prior art keywords
- bruton
- tyrosine kinase
- kinase inhibitors
- crystalline polymorphs
- polymorphs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862745741P | 2018-10-15 | 2018-10-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA53914A true MA53914A (fr) | 2021-08-25 |
Family
ID=68426868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA053914A MA53914A (fr) | 2018-10-15 | 2019-10-15 | Polymorphes cristallins d'inhibiteurs de la tyrosine kinase de bruton |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11820760B2 (fr) |
| EP (1) | EP3866926A1 (fr) |
| JP (1) | JP7476214B2 (fr) |
| MA (1) | MA53914A (fr) |
| WO (1) | WO2020081514A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024233379A1 (fr) * | 2023-05-05 | 2024-11-14 | Biogen Ma Inc. | Inhibiteur de btk pour le traitement de la sclérose en plaques |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| CN104662024B (zh) * | 2012-10-26 | 2016-12-07 | 弗·哈夫曼-拉罗切有限公司 | 酪氨酸激酶抑制剂 |
| WO2015061247A2 (fr) | 2013-10-21 | 2015-04-30 | Merck Patent Gmbh | Composés hétéroaryle servant d'inhibiteurs de la btk et leurs utilisations |
| HUE040346T2 (hu) | 2013-12-11 | 2019-03-28 | Biogen Ma Inc | Az onkológia, neurológia és immunológia területén a humán betegségek kezelésében hasznos biaril vegyületek |
| WO2016201280A1 (fr) | 2015-06-10 | 2016-12-15 | Biogen Ma Inc. | Formes et compositions d'inhibiteurs biaryles de la tyrosine kinase de bruton |
| JOP20190233A1 (ar) * | 2017-04-14 | 2019-10-02 | Biogen Ma Inc | نظائر بنزوازيبين بوصفها عوامل مثبطة لتيروزين كيناز بروتون |
| TW202016097A (zh) | 2018-05-14 | 2020-05-01 | 美商百健Ｍａ公司 | 布魯頓氏酪胺酸激酶之抑制劑 |
-
2019
- 2019-10-15 WO PCT/US2019/056242 patent/WO2020081514A1/fr unknown
- 2019-10-15 EP EP19797924.8A patent/EP3866926A1/fr active Pending
- 2019-10-15 US US17/283,301 patent/US11820760B2/en active Active
- 2019-10-15 JP JP2021545281A patent/JP7476214B2/ja active Active
- 2019-10-15 MA MA053914A patent/MA53914A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US11820760B2 (en) | 2023-11-21 |
| JP7476214B2 (ja) | 2024-04-30 |
| WO2020081514A9 (fr) | 2020-05-22 |
| WO2020081514A1 (fr) | 2020-04-23 |
| EP3866926A1 (fr) | 2021-08-25 |
| US20210387972A1 (en) | 2021-12-16 |
| JP2022502516A (ja) | 2022-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3492462A4 (fr) | Composé amino pyrimidine pour inhiber l'activité de la protéine tyrosine kinase | |
| DK3265084T3 (da) | Farmaceutiske formuleringer af Bruton's tyrosinkinase-hæmmer | |
| ZA201903932B (en) | Imidazopyrazine inhibitors of bruton's tyrosine kinase | |
| IL255831A (en) | Inhibitors of bruton's tyrosine kinase | |
| MA51619A (fr) | Inhibiteurs de la protéine kinase dépendante de l'adn | |
| IL274716A (en) | Synthesis of a proton tyrosine kinase inhibitor | |
| EP3852791A4 (fr) | Activation de la pyruvate kinase r | |
| EP3414234A4 (fr) | Inhibiteurs de la tyrosine kinase de bruton | |
| MA41828A (fr) | Co-cristaux d'un inhibiteur de la tyrosine kinase de bruton | |
| EP3405192A4 (fr) | Inhibiteurs de la tyrosine kinase de bruton | |
| MA53226A (fr) | Sel et formes cristallines d'omecamtiv mecarbil | |
| ZA201903694B (en) | Inhibitors of bruton's tyrosine kinase | |
| IL270693A (en) | Glucuronide prodrugs of janus kinase inhibitors | |
| MA41827A (fr) | Formes solvatées d'un inhibiteur de la tyrosine kinase de bruton | |
| ZA201906887B (en) | Bruton's tyrosine kinase inhibitors | |
| MA42510A (fr) | Formes et compositions d'inhibiteurs biaryles de la tyrosine kinase de bruton | |
| MA52629A (fr) | Agents inhibiteurs de la tyrosine kinase de bruton | |
| MA42509A (fr) | Formes d'adipate et compositions d'inhibiteurs de biaryle de la tyrosine kinase de bruton | |
| EP3833778A4 (fr) | Détection multiplexe d'acides nucléiques | |
| MA55614A (fr) | Formes cristallines d'inhibiteur de pyridazinone trpc | |
| EP4034530A4 (fr) | Inhibiteurs de la protéine kinase i interagissant avec des récepteurs pour le traitement d'une maladie | |
| MA51337A (fr) | Inhibiteurs spiro exo-aza de l'interaction ménine-mll | |
| EP3939588A4 (fr) | Utilisations d'inhibiteurs de la phosphodiestérase | |
| MA52900A (fr) | Inhibiteurs à petites molécules de la famille jak de kinases | |
| MA53914A (fr) | Polymorphes cristallins d'inhibiteurs de la tyrosine kinase de bruton |